Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.

British Journal of Clinical Pharmacology
Xi HeMichael H Court

Abstract

Although in vitro studies indicate that oxazepam is an isoform-selective substrate probe for UDP-glucuronosyltransferase 2B15, the utility of this drug as an in vivo probe is uncertain. The main aim of this study was to determine whether common missense polymorphisms in the UGT2B15 gene (D85Y and K523T) are associated with altered oxazepam pharmacokinetics and pharmacodynamics. We also determined the possible influence of a common deletion polymorphism in the gene encoding UGT2B17, which shows substantial substrate specificity overlap with UGT2B15. Thirty healthy male subjects were administered 15 mg of oxazepam by mouth followed by plasma oxazepam concentration monitoring for 36 h, and pharmacodynamic testing for 8 h. Genotypes were determined by genomic polymerase chain reaction and commercial 5'-nuclease assays. Allele frequencies for D85Y, K523T, UGT2B17del were 47%, 23% and 19%, respectively. Median oxazepam apparent oral clearance was significantly lower in 85YY subjects (1.62 ml min(-1) kg(-1)) compared with 85DD subjects (3.35 ml min(-1) kg(-1); P= 0.003, Student-Newman-Keuls test), whereas 85DY subjects were intermediate (2.34 ml min(-1) kg(-1); P= 0.018 vs. 85DD, P= 0.034 vs. 85YY). Regression analysis indicated that ...Continue Reading

References

Jan 1, 1991·Pharmacology & Therapeutics·J O Miners, P I Mackenzie
Mar 1, 1981·Clinical Pharmacokinetics·D J Greenblatt
May 1, 1983·Clinical Pharmacology and Therapeutics·D R AbernethyR I Shader
Aug 14, 1998·Journal of Clinical Pharmacology·J M ScavoneR I Shader
Nov 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·David N BowserSteven Petrou
Apr 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ji Y ZhangAlan P Breau
Aug 16, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tiia KuuranneRisto Kostiainen
Dec 3, 2003·Trends in Endocrinology and Metabolism : TEM·Alain BélangerSarah Chouinard
Mar 27, 2004·The Journal of Pharmacology and Experimental Therapeutics·Michael H CourtDavid J Greenblatt
Aug 27, 2005·British Journal of Clinical Pharmacology·David J GreenblattRichard I Shader
Sep 6, 2005·Pharmacogenetics and Genomics·Peter I MackenzieDaniel W Nebert
May 18, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Julie M CunninghamStephen N Thibodeau
Oct 16, 2007·Cancer Detection and Prevention·Carla J GallagherPhilip Lazarus
Nov 8, 2008·Chemosphere·Nobumitsu HaniokaShizuo Narimatsu

❮ Previous
Next ❯

Citations

Mar 16, 2011·Archives of Toxicology·Nobumitsu HaniokaShizuo Narimatsu
Mar 19, 2013·The International Journal of Biochemistry & Cell Biology·Andrew RowlandPeter I Mackenzie
Jul 2, 2014·Toxicological Sciences : an Official Journal of the Society of Toxicology·Karthika DivakaranD Gail McCarver
Oct 23, 2014·Drug Metabolism Reviews·Dong Gui HuPeter I Mackenzie
Jan 10, 2012·Cancer Treatment Reviews·Frans L OpdamHenk-Jan Guchelaar
Dec 19, 2015·Research in Veterinary Science·Cyrina D van BeusekomJohannes A Schrickx
Jul 24, 2013·Drug Metabolism and Pharmacokinetics·Mi-Sun HwangJae-Gook Shin
Mar 12, 2015·Drug Metabolism and Pharmacokinetics·Shingo OdaMiki Nakajima
Jan 11, 2018·Pharmaceutics·Steffen G OeserAbby C Collier
Sep 15, 2017·Drug Metabolism Reviews·Ricardo Jorge Dinis-Oliveira
Feb 7, 2019·Physiological Reviews·Robyn MeechPeter I Mackenzie
Nov 10, 2018·The Journal of Pharmacology and Experimental Therapeutics·Aaron M TeitelbaumAllan E Rettie
Apr 5, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Verawan UchaipichatJohn O Miners
Aug 1, 2018·The Pharmacogenomics Journal·M GaibarA Fernández-Santander
May 12, 2020·Frontiers in Pharmacology·José Jaime Martínez-MagañaHumberto Nicolini
Dec 14, 2018·The Journal of Pharmacology and Experimental Therapeutics·Daicia C AllenVerginia C Cuzon Carlson
Sep 5, 2017·Basic & Clinical Pharmacology & Toxicology·Aurélie LombardEunice Yuen
Dec 29, 2020·Frontiers in Genetics·Beatriz Carvalho HenriquesKatherine J Aitchison

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.